1. Perusing the ASCO abstracts with a focus on interferons in malignant melanoma and renal cell carcinoma

   • Stephen K. Carter

   Editorial Pages: 153 - 156

2. Pharmacological studies of ricin in mice and humans

   • Aslak Godal
   • Øystein Fodstad
   • Alexander Pihl

   Original Articles Pages: 157 - 163

3. Tallysomycin S₁₀b: Experimental antitumor activity and toxicity

   • John E. Schurig
   • William C. Rose
   • William T. Bradner

   Original Articles Pages: 164 - 170

4. Studies on the biochemical mechanism of the novel antitumor agent, CI-920

   • David W. Fry
   • Theodore J. Boritzki
   • Robert C. Jackson

   Original Articles Pages: 171 - 175

5. Synergistic antitumor activity of vincristine and VP-16-213

   • Don V. Jackson Jr
   • Tony R. Long
   • Timothy M. Morgan

   Original Articles Pages: 176 - 180

6. Antipyrine metabolism in patients with disseminated testicular cancer and the influence of cytostatic treatment

   • M. W. E. Teunissen
   • P. H. B. Willemse
   • D. D. Breimer

   Original Articles Pages: 181 - 185

7. Clinical pharmacokinetics of high-dose mitomycin C

   • Rudolf B. Schilcher
   • John D. Young
   • Laurence H. Baker

   Original Articles Pages: 186 - 190

8. Cell cycle effects and cellular pharmacology of 5-AZA-2′-deoxycytidine

   • Richard L. Momparler
   • Johanne Samson
   • Georges E. Rivard

   Original Articles Pages: 191 - 194

9. Structure-intestinal transport and structure-metabolism correlations of some potential cancerostatic pyrimidine nucleosides in isolated rat jejunum

   • Ladislav Novotný
   • Hassan Farghali
   • Jiří Beránek

   Original Articles Pages: 195 - 199

10. CNS toxicity and CSF pharmacokinetics of intraventricular DFMO and MGBG in beagle dogs

    • Victor A. Levin
    • Deborah Byrd
    • Janice K. Borcich

    Original Articles Pages: 200 - 205

11. Potential limitations of in vitro clonogenic drug sensitivity assays

    • G. Wei Dong
    • H. D. Preisler
    • R. Priore

    Original Articles Pages: 206 - 210

12. Pharmacokinetic study of VM26 given as a prolonged IV infusion to ovarian cancer patients

    • C. Rossi
    • M. Zucchetti
    • M. D'Incalci

    Original Articles Pages: 211 - 214

13. Phase II study of hepatic artery infusion with 5-fluorouracil, adriamycin, and mitomycin C (FAM) in liver metastases from colorectal carcinoma

    • J. Wils
    • J. Schlangen
    • A. Naus

    Original Articles Pages: 215 - 217

14. A combination of 5-fluorouracil and thymidine in advanced colorectal carcinoma

    • Ahud Sternberg
    • Nicholas J. Petrelli
    • Patrick Creaven

    Original Articles Pages: 218 - 222

15. Methotrexate-related deaths in patients previously treated with cis-diamminedichloride platinum

    • Nissim Haim
    • Amos Kedar
    • Eliezer Robinson

    Original Articles Pages: 223 - 225

16. Bisantrene (NSC 337766) (CL 216,942) in advanced breast cancer

    • Arlene A. Forastiere
    • Michael C. Perry
    • William C. Wood

    Original Articles Pages: 226 - 229

17. Kinetics and sensitivity of daunorubicin in patients with acute leukemia

    • Michael W. DeGregorio
    • Walter M. Holleran
    • Jordan R. Wilbur

    Original Articles Pages: 230 - 234

18. Improved control of cisplatin-induced emesis with a metoclopramide-dexamethasone combination

    • Francesco Cognetti
    • Paola Pinnaro
    • Camillo F. Pollera

    Short Communication Pages: 235 - 237

19. Treatment of myeloblastic sarcoma in the sacral canal with high-dose cytosine arabinoside

    • Michael Barnett
    • Michael Richards
    • Andrew Lister

    Short Communication Pages: 238 - 239

20. Bronchopulmonary effects of elliptinium in anesthetized dogs

    • Alain Eschalier
    • Jeannine Lavarenne
    • Monique Renoux

    Short Communication Pages: 240 - 241

21. Erratum

    • Tadao Niijima
    • Kenkichi Koiso
    • The Japanese Urology Cancer Research Group for Adriamycin

    Erratum Pages: 242 - 242